Pharmacy Question for the Week of April 8, 2019

Pharmacy Compliance Question of the Week


What is the 2019 average sales price (ASP) rate for nonpass-through drugs and biologicals?


For 2019, payment for nonpass-through drugs and biologicals that were not acquired through the 340B Program is made at a single rate of ASP + 6 percent (or ASP – 22.5 percent if acquired under the 340B Program), which provides payment for both the acquisition cost and pharmacy overhead costs associated with the drug or biological. 

This information can be found at 

Disclaimer: Every reasonable effort was made to ensure the accuracy of this information at the time it was published. However, due to the nature of industry changes over time we cannot guarantee its validity after the year it was published.